MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 1072833-77-2
Formula C14H19BCl2N2O4MW 361Research-use catalog entryCOA/SDS by request

Ixazomib

CAS Number: 1072833-77-2

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Available options

Available Options

Package
1 g
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
100 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
250 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
317 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
5 g
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
5 g
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
50 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required

Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.

Loading RDKit molecule structure...
InChIKey: MXAYKZJJDUDWDS-LBPRGKRZSA-NC14H19BCl2N2O4 | MW 361

Chemical Absolute Identifiers

CAS Number

1072833-77-2

PubChem CID

25183872

Molecular Formula

C14H19BCl2N2O4

Molecular Weight

361 g/mol

Exact Mass

360.081493

InChIKey

MXAYKZJJDUDWDS-LBPRGKRZSA-N

IUPAC Name

[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid

SMILES String

CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O

Physical Properties

No physical property values available.

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

Ixazomib (CAS 1072833-77-2) is listed in the Advanced Chemicals portfolio, with molecular formula C14H19BCl2N2O4 and molecular weight 361. 00 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research building-block and synthetic chemistry workflows; structure-derived tags include nitrogen-containing heterocycle, boronic-acid-related structure.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Boronic Acids and EstersSynthetic ChemistryResearch intermediateCustom synthesis building blockResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Proteasome Macropain subunit MB1 (Homo sapiens) — 7 assays; Proteasome component C5 (Homo sapiens) — 4 assays; Proteasome Macropain subunit (Homo sapiens) — 4 assays; NACHT, LRR and PYD domains-containing protein 3 (Mus musculus) — 2 assays; ATP-dependent Clp protease proteolytic subunit (Staphylococcus aureus (strain NCTC 8325)) — 3 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Proteasome Macropain subunit MB1

Homo sapiens · SINGLE PROTEIN · 7 qualifying assays · 6 documents · best pChEMBL 8.54

Experimental evidence source: ChEMBL

Proteasome component C5

Homo sapiens · SINGLE PROTEIN · 4 qualifying assays · 4 documents · best pChEMBL 8.52

Experimental evidence source: ChEMBL

Proteasome Macropain subunit

Homo sapiens · SINGLE PROTEIN · 4 qualifying assays · 4 documents · best pChEMBL 7.52

Experimental evidence source: ChEMBL

NACHT, LRR and PYD domains-containing protein 3

Mus musculus · SINGLE PROTEIN · 2 qualifying assays · 1 documents · best pChEMBL 6.7

Experimental evidence source: ChEMBL

ATP-dependent Clp protease proteolytic subunit

Staphylococcus aureus (strain NCTC 8325) · SINGLE PROTEIN · 3 qualifying assays · 1 documents · best pChEMBL 5.44

Experimental evidence source: ChEMBL

Safety & Handling

Safety and handling reference content is available through documentation requests.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

Ixazomib

Names & Synonyms

MLN 2238MLN-9708 FREE BASEBoronic acid, b-((1R)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)-[(1R)-1-{2-[(2,5-dichlorophenyl)formamido]acetamido}-3-methylbutyl]boronic acid((1R)-1-((2,5-DICHLOROBENZAMIDO)ACETAMIDO)-3-METHYLBUTYL)BORONIC ACID
Show all synonyms
ixazomibum((1R)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)boronic acid((1R)-1-(2-((2,5-dichlorophenyl)formamido)acetamido)-3-methylbutyl)boronic acidBoronic acid, B-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-(R)-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)boronic acid(R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acidIxazomib (MLN2238)Ixazomib [INN]Ixazomib(MLN2238)Ixazomib (USAN)IXAZOMIB [USAN][(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methyl-butyl]boronic acidC14H19BCl2N2O4Ixazomib [USAN:INN]
External Identifiers
EC NUMBER: 810-246-8DSSTOX SUBSTANCE ID: DTXSID701025662CHEMBL ID: CHEMBL2141296CHEBI ID: CHEBI:90942UNII: 71050168A2DRUGBANK ID: DB09570KEGG ID: D10130METABOLOMICS WORKBENCH ID: 152427NCI THESAURUS CODE: C97940RXCUI: 1723735WIKIDATA ID: Q20948663
Literature & Patent References
DOI 10.1016/j.bmc.2024.117874Recent advances in the treatment of gout with NLRP3 inflammasome inhibitors.DOI 10.1016/j.ejmech.2023.115943Design and synthesis of the first PARP-1 and proteasome dual inhibitors to treat breast cancer.PMID 38039793Design and synthesis of the first PARP-1 and proteasome dual inhibitors to treat breast cancer.PMID 39167977Recent advances in the treatment of gout with NLRP3 inflammasome inhibitors.DOI 10.1016/j.ejmech.2023.115187Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma.DOI 10.1038/s41467-023-40064-9A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.DOI 10.6019/EOS300108ECBD screening data for assay EOS300108PMID 36806958Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma.

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

Ixazomib citrateCAS 1239908-20-3
DelanzomibCAS 847499-27-8
B-((1R)-3-Methyl-1-(((2R)-1-oxo-3-phenyl-2-((2-pyrazinylcarbonyl)amino)propyl)amino)butyl)boronic acidCAS 1132709-15-9
((S)-3-Methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acidCAS 1132709-14-8
Bortezomib boronic anhydrideCAS 390800-88-1

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 1239908-20-3Ixazomib citrateCAS 100-33-4PentamidineCAS 100643-71-8DesloratadineCAS 102767-28-2LevetiracetamCAS 179324-69-7BortezomibCAS 868540-17-4CarfilzomibCAS 1002310-00-0Tert-butyl 1-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethylcarbamateCAS 1005174-17-3(E)-3-(2-Propyl-6-(trifluoromethyl)pyridin-3-yl)acrylic acidCAS 1018125-49-92-(3-Cyclopropyl-6-ethyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acidCAS 1018128-07-8Isopropyl 4-chloro-2-methylquinoline-6-carboxylate

RFQ questions for CAS 1072833-77-2

What are the key identifiers for Ixazomib (CAS 1072833-77-2)?

Ixazomib is identified by CAS 1072833-77-2, with molecular formula C14H19BCl2N2O4, molecular weight 361, InChIKey MXAYKZJJDUDWDS-LBPRGKRZSA-N.

Does CAS 1072833-77-2 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Proteasome Macropain subunit MB1, Proteasome component C5, Proteasome Macropain subunit, NACHT, LRR and PYD domains-containing protein 3, ATP-dependent Clp protease proteolytic subunit. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 1072833-77-2?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for Ixazomib?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 1072833-77-2 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.